By clicking the above I certify that I have reviewed the CE information on this page.

Jointly provided by

This activity is supported by independent educational grants from AbbVie, Inc, Celgene Corporation and Novartis Pharmaceuticals Corporation.

The Primer is based on updates to the activity, The Managed Care Review Board™ — An Analysis of Current and Emerging Therapies and Benefit Design Considerations for Psoriasis and Psoriatic Arthritis Primer, which was supported by independent educational grants from Celgene Corporation, Lilly USA, LLC, and Novartis Pharmaceuticals Corporation.